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1. Introduction 
Real-time PCR is based on the revolutionary method of PCR, developed by Kary Mullis in 
the 1980s, which allows researchers to amplify specific pieces of DNA more than a billion-
fold (Saiki, Scharf et al. 1985; Mullis and Faloona 1987; Mullis 1990). PCR-based strategies 
have propelled molecular biology forward by enabling researchers to manipulate DNA 
more easily, thereby facilitating both common procedures, such as cloning, and huge 
endeavors such as the Human Genome Project (Olson, Hood et al. 1989; Ausubel, Brent et al. 
2005). Real-time PCR represents yet another technological leap forward that has opened up 
new and powerful applications for researchers throughout the world. This is in part because 
the enormous sensitivity of PCR has been coupled to the precision afforded by “real-time” 
monitoring of PCR products as they are generated (Valasek and Repa 2005). 
Higuchi and co-workers (Higuchi, Dollinger et al. 1992; Higuchi, Fockler et al. 1993) at 
Roche Molecular Systems and Chiron accomplished the first demonstration of real-time 
PCR. By including a common fluorescent dye called ethidium bromide (EtBr) in the PCR 
and running the reaction under ultraviolet light, which causes EtBr to fluoresce, they could 
visualize and record the accumulation of DNA with a video camera. It has been known 
since 1966 that EtBr increases its fluorescence upon binding of nucleic acids (Le Pecq and 
Paoletti 1966), but only by combining this fluorescent chemistry with PCR and real-time 
videography could real-time PCR be born as it was in the early 1990s. Subsequently, this 
                                                 
* Corresponding Author 
www.intechopen.com
 
Polymerase Chain Reaction 
 
406 
technology quickly matured into a competitive market, becoming commercially widespread 
and scientifically influential (Valasek and Repa 2005).  
Real-time PCR instrumentation was first made commercially available by Applied 
Biosystems in 1996, after which several other companies added new machines to the market. 
Presently, Applied Biosystems, BioGene, Bioneer, Bio-Rad, Cepheid, Corbett Research, 
Idaho Technology, MJ Research, Roche Applied Science, and Stratagene all offer 
instrumentation lines for real-time PCR (BioInformatics 2003).  
Widespread use has also resulted in a multiplicity of names for the technology, each with a 
different shade of meaning. Real-time PCR simply refers to amplification of DNA (by PCR) 
that ismonitored while the amplification is occurring. The benefit of this real-time capability 
is that it allows the researcher to better determine the amount of starting DNA in the sample 
before the amplification by PCR. Present day real-time methods generally involve 
fluorogenic probes that “light up” to show the amount of DNA present at each cycle of PCR. 
“Kinetic PCR” refers to this process as well. “Quantitative PCR” refers to the ability to 
quantify the starting amount of a specific sequence of DNA. This term predates real-time 
PCR because it can refer to any PCR procedure, including earlier gel-based end-point 
assays, that attempts to quantify the starting amount of nucleic acid. Rarely, one might see 
the term “quantitative fluorescent PCR” to designate that the quantification was accomplished 
via measuring output from a fluorogenic probe, although this is redundant because all of the 
present chemistries for real-time PCR are fluorescent. In addition, if reverse transcriptase 
enzymes are used before PCR amplification in any of the above situations, then “RT-PCR” 
replaces “PCR” in the term. Today, the two most common terms, real-time and quantitative, 
are often used interchangeably or in combination, because real-time PCR is quickly becoming 
the method of choice to quantify nucleic acids (Valasek and Repa 2005). 
The basic goal of real-time PCR is to precisely distinguish and measure specific nucleic acid 
sequences in a sample even if there is only a very small quantity. Real-time PCR amplifies a 
specific target sequence ina sample then monitors theamplification progress using 
fluorescent technology. During amplification, how quickly the fluorescent signal reaches a 
threshold level correlates with the amount of original target sequence, thereby enabling 
quantification. In addition, the final product can be further characterized by subjecting it to 
increasing temperatures to determine when the double-stranded product “melts.” This 
melting point is a unique property dependent on product length and nucleotide composition. 
To accomplish these tasks, conventional PCR has been coupled to state-of-the-art fluorescent 
chemistries and instrumentation to becomereal-time PCR (Valasek and Repa 2005). 
2. The chemistries of real-time PCR 
Today fluorescence is exclusively used as the detection method in real-time PCR. Both 
sequence specific probes and non-specific labels are available as reporters. In his initial work 
Higuchi used the common nucleic acid stain ethidium bromide, which becomes fluorescent 
upon intercalating into DNA (Higuchi, Dollinger et al. 1992). Classical intercalators, 
however, interfere with the polymerase reaction, and asymmetric cyanine dyes such as 
SYBR Green I and BEBO have become more popular (Bengtsson, Karlsson et al. 2003; 
Zipper, Brunner et al. 2004). Asymmetric cyanines have two aromatic systems containing 
nitrogen, one of which is positively charged, connected by amethine bridge. These dyes 
have virtually no fluorescence when they are free in solution due to vibrations engaging 
www.intechopen.com
 
Overview of Real-Time PCR Principles 
 
407 
both aromatic systems, which convert electronic excitation energy into heat that dissipates to 
the surrounding solvent. On the other hand the dyes become brightly fluorescent when they 
bind to DNA, presumably to the minor groove, and rotation around the methine bond is 
restricted (Nygren, Svanvik et al. 1998). In PCR the fluorescence of these dyes increases with 
the amount of double stranded product formed, though not strictly in proportion because the 
dye fluorescence depends on the dye: base binding ratio, which decreases during the course of 
the reaction. The dye fluorescence depends also to some degree on the DNA sequence. But a 
certain amount of a particular double-stranded DNA target, in the absence of significant 
amounts of other double-stranded DNAs, gives rise to the same fluorescence every time. 
Hence, the dyes are excellent for quantitative real-time PCR when samples are compared at 
the same level of fluorescence in absence of interfering DNA. Although minor groove 
binding dyes show preference for runs of AT base-pairs (Jansen, Norde´n et al. 1993), 
asymmetric cyanines are considered sequence non-specific reporters in real-time PCR. They 
give rise to fluorescence signal in the presence of any double stranded DNA including 
undesired primer–dimer products. Primer–dimer formation interferes with the formation of 
specific products because of competition of the two reactions for reagents and may lead to 
erroneous readouts. It is therefore good practice to control for primer–dimer formation. This 
can be done by melting curve analysis after completing the PCR. The temperature is then 
gradually increased and the fluorescence is measured as function of temperature. The 
fluorescence decreases gradually with increasing temperature because of increased thermal 
motion which allows for more internal rotation in the bound dye (Nygren, Svanvik et al. 1998). 
However, when the temperature is reached at which the double stranded DNA strand 
separates the dye comes off and the fluorescence drops abruptly (Ririe, Rasmussen et al. 1997). 
This temperature, referred to as the melting temperature, Tm, is easiest determined as the 
maximum of the negative first derivative of the melting curve. Since primer–dimer products 
typically are shorter than the targeted product, they melt at a lower temperature and their 
presence is easily recognized by melting curve analysis (Kubista, Andrade et al. 2006). 
Labeled primers and probes are based on nucleic acids or some of their synthetic analogues 
such as the peptide nucleic acids (PNA) (Egholm, Buchardt et al. 1992) and the locked 
nucleic acids (LNA) (Costa, Ernault et al. 2004). The dye labels are of two kinds: (i) 
fluorophores with intrinsically strong fluorescence, such as fluorescein and rhodamine 
derivatives (Sjöback, Nygren et al. 1995), which through structural design are brought into 
contact with a quencher molecule, and (ii) fluorophores that change their fluorescence 
properties upon binding nucleic acids. Examples of probes with two dyes are the hydrolysis 
probes, popularly called Taqman probes (Holland, Abramson et al. 1991), which can be 
based either on regular oligonucleotides or on LNA (Braasch and Corey 2001), Molecular 
Beacons (Tyagi and Kramer 1996; Tyagi, Bratu et al. 1998), Hybridization probes (Caplin, 
Rasmussen et al. 1999), and the Lion probes (http://www.biotools.net). The dyes form a 
donor–acceptor pair, where the donor dye is excited and transfers its energy to the acceptor 
molecule if it is in proximity. Originally the acceptor molecule was also a dye, but today 
quencher molecules are more popular (Wilson and Johansson 2003). Energy transfer and 
quenching are distance dependent and structural rearrangement of the probe, or, in the case 
of hydrolysis probes, degradation, change the distance between the donor and acceptor and, 
hence, the fluorescence of the system (Kubista, Andrade et al. 2006). 
Probes based on a single dye, whose fluorescence changes upon binding target DNA 
include the LightUp probes (Svanvik, Westman et al. 2000), AllGlo probes 
www.intechopen.com
 
Polymerase Chain Reaction 
 
408 
(http://www.allelogic.com), Displacement probes (Li, Qingge et al. 2002), and the Simple 
probes (http://www.idahotech.com/itbiochem/simpleprobes.html). 
Chemical modifications and alterations of the oligonucleotide backbone are employed in 
some probes to improve the binding properties to the target template. This makes it possible 
to use shorter probes, which is advantageous for the detection of targets with short 
conserved regions such as retroviruses. LightUp probes have a neutral peptide nucleic acid 
(PNA) backbone that binds to DNA with greater affinity than normal oligonucleotides 
(Kubista, Andrade et al. 2006). 
The LightUp probes are 10–12 bases, which is short compared to normal oligonucleotide 
probes that are usually at least 25 bases (http://www.lightup.se). LNA-probes make use of 
modified nucleotides to enhance binding affinity. MGBprobes are hydrolysis probes with a 
minor groove binding molecule attached to the end of the probe to increase affinity for 
DNA, which makes it possible to use shorter probes (Kutyavin, Afonina et al. 2000). 
Examples of modified primers include: Scorpion primers (Whitcombe, Theaker et al. 1999), 
LUX primers (Nazarenko, Lowe et al. 2002), Ampliflour primers (Uehara, Nardone et al. 
1999), and the QZyme system (BD QZymeTM Assays for Quantitative PCR, 2003). As long 
as a single target is detected per sample there is not much of a difference in using a dye or a 
probe. Assay specificity is in both cases determined by the primers. Probes do not detect 
primer–dimer products, but using non-optimized probe assays is hiding the problem under 
the rug. If primer–dimers form they cause problems whether they are seen or not. In probe 
based assays, particularly when high CT values are obtained, one should verify the absence 
of competing primer–dimer products (Kubista, Andrade et al. 2006). The traditional way is 
by gel electrophoresis. Recently, an alternative approach was proposed based on the 
BOXTO dye. BOXTO is a sequence non-specific doublestranded DNA binding dye that has 
distinct spectral characteristics to fluorescein and can be used in combination with FAM 
based probes. The BOXTO and the probe signals are detected in different channels of the 
real-time PCR instrument. While the probe reflects formation of the targeted product as 
usual, the BOXTO dye also reports the presence of any competing primer–dimer products, 
which can be identified by melting curve analysis (Lind, Stahlberg et al. 2006). The great 
advantage of probes is for multiplexing, where several products are amplified in the same 
tube and detected in parallel (Wittwer, Herrmann et al. 2001). Today multiplexing is mainly 
used to relate expression of reporter genes to that of an exogenous control gene in diagnostic 
applications (Mackya 2004), and for single nucleotide polymorphism (SNP) and mutation 
detection studies (Mhlanga and Malmberg 2001; Mattarucchi, Marsoni et al. 2005). Multiplex 
assays are more difficult to design because when products accumulate the parallel PCR 
reactions compete for reagents. To minimize competition limiting amounts of primers must 
be used. Also, primer design is harder, because complementarity must be avoided between 
all the primers. Multiplex assays can be based either on probes or on labeled primers, where 
labeled primers usually give rise to signal from primer–dimer products, while probes do 
not. The different probing technologies have their advantages and limitations. Dyes are 
cheaper than probes but they do not distinguish between products. Hairpin forming probes 
have the highest specificity, because the formation of the hairpin competes with the binding 
to mismatched targets. This makes them most suitable for SNP and multi-site variation 
(MSV) analysis (Bonnet, Tyagi et al. 1999). Hydrolysis probes require two-step PCR to 
function properly, which is not optimal for the polymerase reaction, and short amplicons are 
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necessary to obtain reasonable amplification efficiencies. But they are easier to design than 
hairpin forming probes and an 80% success rate was recently reported (Kubista 2004).  
In summary, a ‘good’probe, independent of chemistry, should have low background 
fluorescence, high fluorescence upon target formation (high signal to noise ratio), and high 
target specificity. The dyes’excitation and emission spectra are important parameters to 
consider when designing multiplex reactions. Spectral overlap in excitation and emission 
should be minimized to keep cross-talk to a minimum (Kubista, Andrade et al. 2006). 
2.1 SYBR green I 
SYBR green I binds to the minor groove of dsDNA, emitting 1,000-fold greater fluorescence 
than when it is free in solution (Wittwer, Herrmann et al. 1997). Therefore, the greater the 
amount of dsDNA present in the reaction tube, the greater the amount of DNA binding and 
fluorescent signal from SYBR green I. Thus any amplification of DNA in the reaction tube is 
measured (Valasek and Repa 2005). 
2.2 BEBO 
The minor groove binding asymmetric cyanine dye BEBO is tested as sequence nonspecific 
label in real-time PCR. The Fluorescence intensity of BEBO increases upon binding to 
double-stranded DNA allowing emission to be measured at the end of the elongation phase 
in the PCR cycle. BEBO concentrations between 0.1 and 0.4 mM generated sufficient 
Fluorescence signal without inhibiting the PCR. A comparison with the commonly used 
reporter dye SYBR Green I shows that the two dyes behave similarly in all important aspects. 
The dye has absorbance and emission wavelengths that can be detected on the FAM channel 
on most common real-time PCR platforms, and shows a strong fluorescence increase when 
bound to dsDNA. BEBO can be used as an unspecific dye for real-time PCR applications or 
other applications where staining of dsDNA is wanted (Bengtsson, Karlsson et al. 2003). 
2.3 BOXTO 
The unsymmetrical cyanine dyes BOXTO and its positive divalent derivative BOXTO-PRO 
were studied as real-time PCR reporting fluorescent dyes and compared to SYBR GREEN I 
(SG). Unmodified BOXTO showed no inhibitory effects on real-time PCR, while BOXTO-
PRO showed complete inhibition, sufficient fluorescent signal was acquired when 0.5–1.0 
µM BOXTO was used with RotorGene and iCycler platforms. Statistical analysis showed 
that there is no significant difference between the efficiency and dynamic range of BOXTO 
and SG (Ahmad 2007). 
2.4 5' nuclease (TaqMan) probes 
Hydrolysis probes (also called 5/-nuclease probes because the 5/-exonuclease activity of 
DNA polymerase cleaves the probe) offer an alternative approach to the problem of 
specificity. These are likely the most widely used fluorogenic probe format (Mackay 2004) 
and are exemplified by TaqMan probes. In terms of structure, hydrolysis probes are 
sequence- specific dually fluorophore-labeled DNA oligonucleotides (Valasek and Repa 
2005). One fluorophore is termed the quencher and the other is the reporter. When the 
quencher and reporter are in close proximity, that is, they are both attached to the same 
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short oligonucleotide; the quencher absorbs the signal from the reporter (Valasek and Repa 
2005). This is an example of fluorescence resonance energy transfer (also called Forster 
transfer) in which energy is transferred from a “donor” (the reporter) to an “acceptor” (the 
quencher) fluorophore. During amplification, the oligonucleotide is broken apart by the 
action of DNA polymerase (5/-nuclease activity) and the reporter and quencher separate, 
allowing the reporter’s energy and fluorescent signal to be liberated. Thus destruction or 
hydrolysis of the oligonucleotide results in an increase of reporter signal and corresponds 
with the specific amplification of DNA (Valasek and Repa 2005). Examples of common 
quencher fluorophores include TAMRA, DABCYL, and BHQ, whereas reporters are more 
numerous (e.g., FAM, VIC, NED, etc). Hydrolysis probes afford similar precision as SYBR 
green I (Wilhelm, Pingoud et al. 2003), but they give greater insurance regarding the 
specificity because only sequence-specific amplification is measured. In addition, hydrolysis 
probes allow for simple identification of point mutations within the amplicon using melting 
curve analysis (Valasek and Repa 2005). 
2.5 Molecular beacons 
Molecular beacons are similar to TaqMan probes but are not designed to be cleaved by the 5' 
nuclease activity of Taq polymerase. These probes have a fluorescent dye on the 5' end and a 
quencher dye on the 3' end of the oligonucleotide probe. A region at each end of the 
molecular beacon probe is designed to be complementary to itself, so at low temperatures, 
the ends anneal, creating a hairpin structure. This integral annealing property positions the 
two dyes in close proximity, quenching the fluorescence from the reporter dye (Espy, Uhl et 
al. 2006). The central region of the probe is designed to be complementary to a region of the 
PCR amplification product. At high temperatures, both the PCR amplification product and 
probe are single stranded. As the temperature of the PCR is lowered, the central region of 
the molecular beacon probe binds to the PCR product and forces the separation of the 
fluorescent reporter dye from the quenching dye. The effects of the quencher dye are 
obviated and a light signal from the reporter dye can be detected. If no PCR amplification 
product is available for binding, the probe reanneals to itself, forcing the reporter dye and 
quencher dye together, preventing fluorescent signal (Espy, Uhl et al. 2006). Typically, a 
single molecular beacon is used for detection of a PCR amplification product and multiple 
beacon probes with different reporter dyes are used for single nucleotide polymorphism 
detection. By selection of appropriate PCR temperatures and/or extension of the probe 
length, molecular beacons will bind to the target PCR product when an unknown nucleotide 
polymorphism is present but at a slight cost of reduced specificity. There is not a specific 
temperature thermocycling requirement for molecular beacons, so temperature optimization 
of the PCR is simplified (Espy, Uhl et al. 2006). 
2.6 FRET hybridization probes 
FRET hybridization probes, also referred to as LightCyclerprobes; represent a third type of 
probe detection format commonly used with real-time PCR testing platforms. FRET 
hybridization probes are two DNA probes designed to anneal next to each other in a head-
to-tail configuration on the PCR product. The upstream probe has a fluorescent dye on the 3' 
end and the downstream probe has an acceptor dye on the 5' end. If both probes anneal to 
the target PCR product, fluorescence from the 3' dye is absorbed by the adjacent acceptor 
dye on the 5' end of the second probe. The second dye is excited and emits light at a third 
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wavelength and this third wavelength is detected. If the two dyes do not align together 
because there is no specific DNA for them to bind, then FRET does not occur between the 
two dyes because the distances between the dyes are too great. A design detail of FRET 
hybridization probes is the 3' end of the second (downstream) probe is phosphorylated to 
prevent it from being used as a primer by Taq during PCR amplification. The two probes 
encompass a region of 40 to 50 DNA base pairs, providing exquisite specificity (Espy, Uhl et 
al. 2006). FRET hybridization probe technology permits melting curve analysis of the 
amplification product. If the temperature is slowly raised, eventually the probes will no 
longer be able to anneal to the target PCR product and the FRET signal will be lost. The 
temperature at which half the FRET signal is lost is referred to as the melting temperature of 
the probe system (Espy, Uhl et al. 2006). The Tm depends on the guanine plus cytosine 
content and oligonucleotide length. In contrast to TaqMan probes, a single nucleotide 
polymorphism in the target DNA under a hybridization FRET probe will still generate a 
signal, but the melting curve will display a lower Tm. The lowered Tm can be characteristic 
for a specific polymorphism underneath the probes; however, a lowered Tm can also be the 
result of any sequence difference under the probes. The target PCR product is detected and 
the altered Tm informs the user there is a difference in the sequence being detected. 
Generally, more than three base pair differences under a FRET hybridization probe prevent 
hybridization at typical annealing temperatures and are not detected (Espy, Uhl et al. 2006). 
This trait of FRET hybridization probes is advantageous in cases where the genome of the 
organism is known to mutate at a high frequency, such as with viruses. When a single or 
limited number (<3) of known polymorphisms occur between two similar targets, FRET 
hybridization probes can also be used for discriminating strains of organisms (Espy, Uhl et 
al. 2006). Like molecular beacons, there is not a specific thermocycling temperature 
requirement for FRET hybridization probes. Molecular beacons and FRET hybridization 
probes, unlike TaqMan probes, are both recycled (conserved) in each round of PCR 
temperature cycle. Also, for Molecular beacons and FRET hybridization probes, unlike 
TaqMan probes, fluorescent signal does not accumulate as PCR product accumulates after 
each PCR cycle (Espy, Uhl et al. 2006). 
2.7 Scorpions 
Scorpions combine the detection probe with the upstream PCR primer (Whitcombe, Theaker 
et al. 1999) and consist of a fluorophore on the 5′ end, followed by a complementary stem-
loop structure (also containing the specific probe sequence), quencher dye, DNA 
polymerase blocker (a nonamplifiable monomer that prevents DNA polymerase extension), 
and finally a PCR primer on the 3′ end. The probe sequence contained within the hairpin 
allows the scorpion to anneal to the template strand, which separates the quencher for the 
fluorophore and results in increased fluorescence. Because sequence-specific priming and 
probing is a unimolecular event, scorpions perform better than bimolecular methods under 
conditions of rapid cycling such as the LightCycler (Thelwell, Millington et al. 2000). Cycling 
is performed at a temperature optimal for DNA polymerase activity instead of the reduced 
temperature necessary for the 5′ nuclease assay. Scorpions are specific enough for allele 
discrimination and may be multiplexed easily (Thelwell, Millington et al. 2000).  The 
scorpion chemistry has been improved with the creation of duplex scorpions in which the 
reporter dye/probe and quencher fragment are on separate, complementary molecules 
(Solinas, Brown et al. 2001). The duplex scorpions still bind in a unimolecular event, but 
because the reporter and quenchers are on separate molecules, they yield greater signal 
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intensity because the reporter and quencher can separate completely (Wong and Medrano 
2005). 
2.8 Sunrise™ primers 
Created by Oncor (Gaithersburg, MD, USA), Sunrise primers are similar to scorpions in that 
they combine both the PCR primer and detection mechanism in the same molecule 
(Nazarenko, Bhatnagar et al. 1997). These probes consist of a dual-labeled (reporter and 
quencher fluorophores) hairpin loop on the 5′ end, with the 3′ end acting as the PCR primer. 
When unbound, the hairpin is intact, causing reporter quenching via FRET. Upon 
integration into the newly formed PCR product, the reporter and quencher are held far 
enough apart to allow reporter emission (Wong and Medrano 2005). 
2.9 LUX™ fluorogenic primers 
Light upon extension (LUX) primers (Invitrogen, Carlsbad, CA, USA) are self-quenched 
single-fluorophore labeled primers almost identical to Sunrise primers. However, rather 
than using a quencher fluorophore, the secondary structure of the 3′ end reduces initial 
fluorescence to a minimal amount (Nazarenko, Lowe et al. 2002). Because this chemistry 
does not require a quencher dye, it is much less expensive than dual-labeled probes. While 
this system relies on only two oligonucleotides for specificity, unlike the SYBR Green I 
platform in which a dissociation curve is used to detect erroneous amplification, no such 
convenient detection exists for the LUX platform. Agarose gels must be run to ensure the 
presence of a single PCR product, a step that is extremely important not only for the LUX 
primers but also for the Sunrise primers and scorpions because PCR priming and probe 
binding are not independent in these chemistries (Wong and Medrano 2005). 
2.10 Light-up probes 
Light-up probes are peptide nucleic acids (PNAs) that use thiazole orange as the fluorophor. 
Upon hybridisation with DNA, duplex or triplex structures are formed with increased 
fluorescence intensity of the fluorophor. A quencher is not required. This technique is 
limited by unspecific fluorescence, which increases during PCR and therefore restricts the 
achievable sensitivity (Isacsson, Cao et al. 2000; Svanvik, Stahlberg et al. 2000;Svanvik, 
Westman et al. 2000). Some other formats use the increasing quench as indicator for product 
accumulation (Crockett and Wittwer 2001; Kurata, Kanagawa et al. 2001). In this case, the 
fluorescence is quenched by a guanine residue of the PCR product. These probes are 
comparatively inexpensive and easy to construct; however, measurement of the decrease of 
a signal is problematic, especially during the early exponential phase in which only very few 
probes are quenched (Wilhelm and Pingoud 2003). 
2.11 Eclipse probe 
qPCR assays using an Eclipse probe employ two primers and a sequence-specific 
oligonucleotide probe. The probe is complementary to a sequence within the amplicon and 
contains a fluorescent reporter at the 3' end, a quencher at the 5' end, and a minor groove 
binder (Bio-Rad Laboratories 2006). The unhybridized probe adopts a conformation that 
brings the reporter and quencher together, quenching the reporter. During the annealing 
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step of PCR, the probe hybridizes to the target with the help of the minor groove binder.  
The probe thus becomes linearized, separating the reporter and quencher and allowing the 
reporter to fluoresce. The resulting fluorescent signal is proportional to the amount of 
amplified product in the sample (Bio-Rad Laboratories 2006). 
2.12 Amplifluor primer 
qPCR assays using Amplifluor chemistry employ two target-specific primers and one 
universal primer called the UniPrimer. The first target-specific primer contains a 5' 
extension sequence called the Z-sequence that is also found at the 3' end of the UniPrimer. 
The UniPrimer forms a hairpin structure (Bio-Rad Laboratories 2006). A fluorescent reporter 
and a quencher are attached at the 5' and the 3' ends of the stem structure, respectively. In 
the hairpin conformation, the reporter fluorescence is quenched due to its proximity to the 
quencher. During the first amplification cycle, the first target-specific primer (with the Z-
sequence) hybridizes to the template and is extended. During the second amplification cycle, 
the second target-specific primer is used to synthesize a new target template that contains a 
sequence complementary to the Z-sequence. The product from the second amplification cycle 
can then serve as the template for the UniPrimer. In the third amplification cycle, the extended 
UniPrimer serves as a template for the next amplification cycle (Bio-Rad Laboratories 2006). In 
the fourth cycle, extension of the template through the hairpin region of the UniPrimer causes 
the UniPrimer to open up and adopt a linear configuration, which allows the reporter to 
fluoresce. Exponential amplification using the second target-specific primer and the UniPrimer 
occurs in subsequent amplification cycles. The resulting fluorescent signal is proportional to 
the amount of amplified product in the sample (Bio-Rad Laboratories 2006). 
2.13 BD QZyme primer 
qPCR assays using BD QZyme primers employ a target-specific zymogene primer, a target-
specific reverse primer, and a universal oligonucleotide substrate. The oligonucleotide 
contains a fluorescent reporter on the 5' end and a quencher on the 3' end. When 
oligonucleotide substrate is intact, the fluorescence of the reporter is quenched by the 
quencher due to their proximity (Bio-Rad Laboratories 2006). The zymogene primer 
contains a sequence that encodes a catalytic DNA. During the first amplification cycle, the 
zymogene primer is extended. In the second cycle, the product of the first cycle is used as 
the template by the target-specific reverse primer, which is extended to create a new target 
sequence containing a catalytic DNA region. In the subsequent annealing step, the 
fluorescently labeled oligonucleotide substrate hybridizes to the catalytic DNA sequence 
and is cleaved. This cleavage separates the reporter from the quencher, resulting in a 
fluorescent signal that is proportional to the amount of amplified product in the sample 
(Bio-Rad Laboratories 2006). 
3. Design and optimization of SYBR Green I reactions 
A SYBR Green I assay uses a pair of PCR primers that amplifies a specific region within the 
target sequence of interest and includes SYBR Green 1 for detecting the amplified product. 
The steps for developing a SYBR Green I assay are: 
1. Primer design and amplicon design 
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2. Assay validation and optimization 
A) Primer and Amplicon Design: 
A successful real-time PCR reaction requires efficient and specific amplification of the 
product. Both primers and target sequence can affect this efficiency. Therefore, care must be 
taken when choosing a target sequence and designing primers. A number of free and 
commercially available software programs are available for this purpose. One popular web-
based program for primer design is Primer3 (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi).  A commercially available program such as Beacon Designer 
software performs both primer design and amplicon selection (Bio-Rad Laboratories 2006).  
B) Guidelines of amplicon design: 
1. Design amplicon to be 75–200 bp.Shorteramplicons are typically amplified with higher 
efficiency. An amplicon should be at least 75 bp to easily distinguish it from any 
primer-dimers that might form 
2. Avoid secondary structure if possible. Use programs such as mfold 
http://www.bioinfo.rpi.edu/applications/mfold/) to predict whether an amplicon 
will form any secondary structure at annealing temperature. See Real-Time PCR: 
General Considerations (Bio-Rad bulletin 2593) for more details 
3. Avoid templates with long (>4) repeats of single bases 
4. Maintain a GC content of 50–60% 
C) Parameters of primer design: 
1. Design primers with a GC content of 50–60% 
2. Maintain a melting temperature (Tm) between 50ºC and 65ºC. We calculate Tm values 
using the nearest-neighbor method with values of 50 mM for salt concentration and 300 
nM for oligonucleotide concentration 
3. Avoid secondary structure; adjust primer locations outside of the target sequence 
secondary structure if required 
4. Avoid repeats of Gs or Cs longer than three bases 
5. Place Gs and Cs on ends of primers 
6. Check sequence of forward and reverse primers to ensure no 3' complementarity (avoid 
primer-dimer formation)   
7. Verify specificity using tools such as the Basic Local Alignment Search Tool 
(http://www.ncbi.nlm.nih.gov/blast/) 
D) Assay Validation and Optimization: 
Components a SYBR Green I qPCR reaction: 
1. PCR master mix with SYBR Green I 
2. Template  
3. Primers 
Preformulated real-time PCR master mixes containing buffer, DNA polymerase, dNTPs, 
and SYBR Green I dye are available from several vendors.  
Optimized SYBR Green I qPCR reactions should be sensitive and specific and should exhibit 
good amplification efficiency over a broad dynamic range (Bio-Rad Laboratories 2006).  
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Steps of to determine the performance of your SYBR Green I qPCR assay: 
a. Identify the optimal annealing temperature for your assay 
b. Construct a standard curve to evaluate assay performance 
E) Annealing Temperature Optimization: 
The optimal annealing temperature can easily be assessed on qPCR instruments that have a 
temperature gradient feature, such as the MiniOpticon™, MyiQ™, DNA Engine Opticon®, 
Opticon™ 2, iCycleriQ®, Chromo4™, and iQ™5 systems.  
A gradient feature allows you to test a range of annealing temperatures simultaneously, so 
optimization reactions can be performed in a single experiment. 
To find the optimal annealing temperature for reaction, recommend testing a range of 
annealing temperatures above and below the calculated Tm of the primers. 
Because SYBR Green I binds to all dsDNA, it is necessary to check the specificity of your 
qPCR assay by analyzing the reaction product(s). To do this, use the melt-curve function on 
your real-time instrument and also run products on an agarose gel. An optimized SYBR 
Green I qPCR reaction should have a single peak in the melt curve, corresponding to the 
single band on the agarose gel. 
Nonspecific products that may have been co-amplified with the specific product can be 
identified by melt-curve analysis. In this example, the specific product is the peak with a Tm 
of 89°C and corresponds to the upper band on the gel. The nonspecific product is the peak 
with a Tm of 78°C and corresponds to the lower band in the gel. By comparing the gel image 
with the melt curve, you can identify peaks in the melt curve that correspond to specific 
product, additional nonspecific bands, and primer-dimers. If nonspecific products such as 
primer-dimers are detected by melt-curve analysis, recommend that redesign primers (Bio-
Rad Laboratories 2006). 
F) Assay Performance Evaluation Using Standard Curves: 
The efficiency, reproducibility, and dynamic range of a SYBR Green I assay can be 
determined by constructing a standard curve using serial dilutions of a known template. 
The efficiency of the assay should be 90–105%, the R2 of the standard curve should be >0.980 
or r > |–0.990|, and the CT values of the replicates should be similar.  
It is important to note that the range of template concentrations used for the standard curve 
must encompass the entire range of template concentration of the test samples to show that 
results from the test samples are within the linear dynamic range of the assay. If the test 
samples give results outside of the range of the standard curves, one of the following must 
be performed: 
1. Construct a wider standard curve covering the test sample concentrations and perform 
analysis to ensure that the assay is linear in that new range 
2. If the test samples give a lower CT than the highest concentration of standards used in 
the standard curve, repeat the assay using diluted test samples 
3. If the test samples give a higher CT than the lowest concentration of standards used in 
the standard curve, repeat the assay using larger amounts of the test samples 
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4. Design and optimization of TaqManProbe reactions 
A TaqMan assay uses a pair of PCR primers and a dual-labeled target-specific fluorescent 
probe. The steps for developing a TaqMan assay are: 
a. Primer and probe design 
b. Assay validation and optimization 
A. Primer and Probe Design: 
As with any qPCR reaction, TaqMan-based assays require efficient and specific 
amplification of the product. Typically, the primers are designed to have an annealing 
temperature between 55 and 60oC. We recommend using software such as Beacon Designer 
for designing your TaqMan primers and TaqMan probe.. Because the dual-labeled probe is 
the most costly component of a TaqMan assay, suggested that order the two primers and 
validate their performance using SYBR Green I before ordering the dual-labeled probe.  
The TaqMan probe should have a Tm 5–10°C higher than that of the primers.  In most cases, 
the probe should be <30 nucleotides and must not contain a G at its 5' end because this 
could quench the fluorescent signal even after hydrolysis. Choose a sequence within the 
target that has a GC content of 30–80%, and design the probe to anneal to the strand that has 
more Gs than Cs (so the probe contains more Cs than Gs).  
An important aspect of designing a TaqMan probe is reporter and quencher selection. We 
recommend using FAM-labeled probes when designing singleplex reactions, because they 
are inexpensive and readily available, perform well, and can be detected by all instruments 
currently on the market. 
Another important consideration for obtaining accurate real-time qPCR data is probe 
quality. Even a perfectly designed probe can fail if the probe is improperly synthesized or 
purified. Improper removal of uncoupled fluorescent label, inefficient coupling, and/or 
poor quenching can produce high fluorescent background or noise. A low signal-to-noise 
ratio results in decreased sensitivity and a smaller linear dynamic range. Two probes with 
identical sequences and identical fluorophore labels can be measurably different when 
synthesized by different suppliers or even at different times by the same supplier.  
B. Assay Validation and Optimization: 
A TaqMan probe-based qPCR reaction contains the following components: 
1. PCR master mix  
2. Template  
3. Primers 
4. Probe(s) 
Preformulated PCR master mixes containing buffer, DNA polymerase, and dNTPs are 
commercially available from several vendors. For TaqMan assays, we recommend using 
iQ™ supermix with 300 nM of each of the two primers and 200 nM of probe(s).  TaqMan 
assays require careful attention to temperature conditions. A typical TaqMan protocol 
contains a denaturation step followed by a combined annealing and extension step at 55–
60°C, instead of the traditional three-step PCR cycle of denaturation, annealing, and 
extension. This is to ensure that the probe remains bound to its target during primer 
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extension. Typical TaqMan probes for nucleic acid quantification are designed to have a Tm 
of 60–70°C. An optimized TaqMan assay should be sensitive and specific, and should 
exhibit good amplification efficiency over a broad dynamic range.  
In short, construct a standard curve using dilutions of a known template and use this curve 
to determine the efficiency of the assay along with R2 or r of the regression line. The 
efficiency of the reaction should be between 90 and 105%, the R2 should be >0.980 or r > |–
0.990|, and the replicates should give similar CT values. If the assay performs within these 
specifications, you are ready to start your experiment. If the assay performs outside these 
specifications, we suggest that you redesign your primers and TaqMan probe. It is 
important to note that the range of template concentrations used for the standard curve 
must encompass the entire range of template concentrations of the test samples to 
demonstrate that results from the test samples are within the dynamic range of the assay 
(Bio-Rad Laboratories 2006). If test samples give results outside the range of the standard 
curve, one of the three following steps must be performed: 
1. Construct a wider standard curve covering the test sample concentrations and perform 
analysis to ensure that the assay is linear in that new range 
2. If the test samples give a lower CT than the highest concentration of standards used in 
the standard curve, repeat the assay using diluted test samples 
3. If the test samples give a higher CT than the lowest concentration of standards used in 
the standard curve, repeat the assay using larger amounts of the test samples 
5. The instrumentation of real-time PCR 
A critical requirement for real-time PCR technology is the ability to detect the fluorescent 
signal and record the progress of the PCR. Because fluorescent chemistries require both a 
specific input of energy for excitation and a detection of a particular emission wavelength, 
the instrumentation must be able to do both simultaneously and at the desired wavelengths. 
Thus the chemistries and instrumentation are intimately linked (Valasek and Repa 2005). 
At present, there are three basic ways in which real-time instrumentation can supply the 
excitation energy for fluorophores: by lamp, light-emitting diode (LED), or laser. Lamps are 
classified as broad-spectrum emission devices, whereas LEDs and lasers are narrow 
spectrum. Instruments that utilize lamps (tungsten halogen or quartz tungsten halogen) 
may also include filters to restrict the emitted light to specific excitation wavelengths. 
Instruments using lamps include Applied Biosystem’s ABI Prism 7000, Stratagene’s Mx4000 
and Mx3000P, and Bio-Rad’s iCycleriQ. LED systems include Roche’s LightCycler, 
Cepheid’s SmartCycler, Corbett’s Rotor-Gene, and MJ Research’s DNA Engine Opticon 2. 
The ABI Prism 7900HT is the sole machine to use a laser for excitation (Valasek and Repa 
2005). To collect data, the emission energies must also be detected at the appropriate 
wavelengths. Detectors include charge-coupled device cameras, photomultiplier tubes, or 
other types of photodetectors. Narrow wavelength filters or channels are generally 
employed to allow only the desired wavelength(s) to pass to the photodetector to be 
measured. Usually, multiple discrete wavelengths can be measured at once, which allows 
for multiplexing, i.e., running multiple assays in a single reaction tube (Valasek and Repa 
2005). Another portion of the instrumentation consists of a thermocycler to carry out PCR. 
Of particular importance for real-time PCR is the ability of the thermocycler to maintain a 
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consistent temperature among all sample wells, as any differences in temperature could lead 
to different PCR amplification efficiencies. This is accomplished by using a heating block 
(Peltier based or resistive), heated air, or a combination of the two. As one might expect, 
heating blocks generally change temperature more slowly than heated air, resulting in 
longer thermocycling times. For example, Roche’s LightCycler models utilizing heated air 
can perform 40 cycles in 30 min, whereas Applied Biosystem’s ABI Prism 7900HT utilizing a 
Peltier-based heating block take s 1 h 45 min (Valasek and Repa 2005).  Real-time 
instrumentation certainly would not be complete without appropriate computer hardware 
and data-acquisition and analysis software. Software platforms try to simplify analysis of 
real-time PCR data by offering graphical output of assay results including amplification and 
dissociation (melting point) curves. The amplification curve gives data regarding the 
kinetics of amplification of the target sequence, whereas the dissociation curve reveals the 
characteristics of the final amplified product (Valasek and Repa 2005). 
5.1 Comparison of the different systems 
Essentially, each real time PCR instrument consists of a computer-controlled thermocycler 
integrated with fluorescent detection system and dedicated software to analyze the result. 
Some systems can detect four different wave lengths (I-cycler, Mx4000 [stratagene] and 
Smart Cycler®, Version 2.0 Light Cycler®) whereas others can detect two different 
wavelengths (Light Cycler®). The Light Cycler® and Smart Cycler® are capable of 
performing rapid-cycle real time PCR because the reaction is set-up in capillaries or 
especially designated tubes. Both have optimized heating- cooling characteristic. A complete 
amplification protocol can be performed in 30-45 minutes (Myi ; Giulietti, Overbergh et al. 
2001; Soheili and Samiei 2005).  The Smart Cycler® is a combination of 16 individual, one 
tube real time PCR units. It is capable of performing a different PCR program on each of 16 
reaction tubes. This is very useful for a rapid optimization of the assay as many variables 
can be tested at the same time. The Bio-Rad I-cycler IQ® instrument can perform real time 
amplification with a temperature gradient for specific PCR steps, allowing the optimization 
of real time PCR assay. The spectrofluorometers in the thermal cycler have a number of 
differences. Laser-based systems are tuned to excite each fluorophore at a specific 
wavelength and provide maximum efficiency. Lamp-based systems provide a broad 
excitation range that can be filtered to work with a number of fluorophores. The laser source 
not only gives brighter illumination to the fluorophore signal, but also produces less 
background noise(Myi ; Giulietti, Overbergh et al. 2001; Soheili and Samiei 2005).  
In conclusion, real time PCR is a powerful advancement of the basic PCR technique. The 
important steps in deciding which particular assay format to use are related to the type of 
data required. The requirement for a research laboratory is quite distinct from those of a 
diagnostic laboratory. For the latter, probe confirmation of the PCR product is an essential 
part of the assay, whereas SYBR green detection may be sufficient for many other 
applications such as quantifying expression of a gene. All of the real-time PCR machines 
analyzed are capable of detecting PCR product in real time and a specific assay can be made 
optionally on every system. However, there are some decisions to be made when selecting 
among different formats. The choice of system is dependent on individual laboratory needs 
(Myi ; Giulietti, Overbergh et al. 2001; Soheili and Samiei 2005). Considering diagnostic 
applications, the Light Cycler® or Smart Cycler® may obtain faster results for urgent assays.  
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This could reduce the time of analysis to result from 3-4 hours to 1.5 hours. On the other 
hand, if sensitivity is the most important issue, these machines, with their smaller reaction 
volume and consequently lower sensitivity, wouldn't be the first choice. The ABI 7700 and 
Bio-Rad -I-Cycler IQ® have a 96 well format, enabling higher throughput than other 
systems. The 384-well plates, as designed by ABI for use in the 7900 HT system, can further 
enhance through put. For diagnostic application, internal control of nucleic acid isolation 
and PCR inhibition, it is essential to obtain valid results. This can be achieved using the 
system that enables multi-color detection, such as the I-Cycler IQ® and the Smart Cycler®. 
Recently, a multi-color format of the Light Cycler® is also present in market. Multiplex real-
time PCRs can be developed for three different targets and an internal control by using the 
four detection wavelengths possible in multicolor detection. As a matter of fact, the choice of 
which real time system to use depends on the range of application required. To achieve 
meaningful results, each assay must be validated and optimized for the particular system 
chosen (Myi ; Giulietti, Overbergh et al. 2001; Soheili and Samiei 2005). 
6. Advantages of real-time PCR quantitation 
There are many methods in molecular biology for measuring quantities of target nucleic 
acid sequences. However, most of these methods exhibit one or more of the following 
shortcomings: they are time consuming, labor intensive, insufficiently sensitive, non-
quantitative, require the use of radioactivity, or have a substantial probability of cross 
contamination (Reischl, Wittwer et al. 2002). These methods include but are not limited to 
Northern and Southern hybridizations, HPLC, scintillation proximity assay, PCR-ELISA, 
RNase protection assay, in situ hybridization, and various gel electrophoresis PCR end-
point systems (Valasek and Repa 2005). Real-time PCR has distinct advantages over these 
earlier methods for several reasons. Perhaps the most important is its ability to quantify 
nucleic acids over an extraordinarily wide dynamic range (at least 5 log units). This is 
coupled to extreme sensitivity, allowing the detection of less than five copies (perhaps only 
one copy in some cases) of a target sequence, making it possible to analyze small samples 
like clinical biopsies or miniscule lysates from laser capture microdissection. With 
appropriate internal standards and calculations, mean variation coefficients are 1–2%, 
allowing reproducible analysis of subtle gene expression changes even at low levels of 
expression (Klein 2002; Luu-The, Paquet et al. 2005). In addition, all real-time platforms are 
relatively quick, with some affording high-throughput automation. Finally, real-time PCR is 
performed in a closed reaction vessel that requires no post-PCR manipulations, thereby 
minimizing the chances for cross contamination in the laboratory (Valasek and Repa 2005). 
7. Limitations of real-time PCR quantitation 
There are several limitations to real-time PCR methods. The majority of these are present in 
all PCR or RT-PCR-based techniques. Real-time PCR is susceptible to PCR inhibition 
bycompounds present in certain biological samples. For example, clinical and forensic uses 
for real-timePCR may be affected by inhibitors found in certain body fluidssuch as 
hemoglobin or urea (Wilson 1997). Food microbiological applications may encounter 
organic and phenolic inhibitors (Wilson 1997). To circumvent this problem, alternative DNA 
polymerases (e.g., Tfl, Pwo, Tth, etc.) that are resistant to particular inhibitors can be used. 
Other limitations primarily concern real-time PCR- based analysis of gene expression 
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(Bustin 2000; Bustin 2002;Bustin and Nolan 2004). Because of the necessary use of RNA in an 
extra enzymatic step, more problems have the opportunity to occur. RNA itself is extremely 
labile compared with DNA, and therefore isolation must be carefully performed to ensure 
both the integrity of the RNA itself and the removal of contaminating nucleases, genomic 
DNA, and RT or PCR inhibitors. This can be a problem with any sample source, but clinical 
samples are of special concern because inconsistencies in sample size, collection, storage, 
and transport can lead to a variable quality of RNA templates. Conversion of RNA to cDNA 
during the RT reaction is also subject to variability because multiple reverse transcriptase 
enzymes with different characteristics exist, and different classes of oligonucleotides (e.g., 
random, poly-dT, or gene specific primers) can be used to prime RT (Valasek and Repa 
2005). Probably the largest present limitation of real-time PCR, however, is not inherent in 
the technology but rather resides in human error: improper assay development, incorrect 
data analysis, or unwarranted conclusions. In our experience using real-time PCR for gene 
expression analysis, real-time PCR primer sets must be designed and validated by stringent 
criteria to ensure specificity and accuracy of the results. For microbiology, false positives or 
negatives must be considered when designing an assay to detect pathogens. Amplification 
and melting curves must be visually inspected while independent calculations based on 
these curves should be double-checked for accuracy. Real-time PCR gene expression 
analysis measures mRNA levels and, therefore, only suggests possible changes in protein 
levels or function rather than demonstrating them. And although there is a tight connection 
between gene expression and gene product function (Brown and Botstein 1999)(8), this is 
certainly not always the case, and formal demonstration may be needed for a given research 
project. Of course, conclusions based on data derived from real-time PCR are best utilized 
when the biological context is well understood (Bustin 2002). 
8. Types of real-time quantification 
1. Absolute Quantitation 
Absolute quantitation uses serially diluted standards of known concentrations to generate a 
standard curve. The standard curve produces a linear relationship between Ct and initial 
amounts of total RNA or cDNA, allowing the determination of the concentration of 
unknowns based on their Ct values (Heid, Stevens et al. 1996). This method assumes all 
standards and samples have approximately equal amplification efficiencies (Souaze, 
Ntodou-Thome et al. 1996). In addition, the concentration of serial dilutions should 
encompass the levels in the experimental samples and stay within the range of accurately 
quantifiable and detectable levels specific for both the real-time PCR machine and assay.The 
PCR standard is a fragment of double-stranded DNA (dsDNA), single-stranded DNA 
(ssDNA), or cRNA bearing the target sequence (Wong and Medrano 2005).  A simple 
protocol for constructing a cRNA standard for one-step PCR can be found in Fronhoffs et al. 
(Fronhoffs, Totzke et al. 2002), while a DNA standard for two-step real-time PCR can be 
synthesized by cloning the target sequence into a plasmid (Gerard, Olsson et al. 1998), 
purifying a conventional PCR product (Liss 2002), or directly synthesizing the target nucleic 
acid. The standard used must be a pure species. DNA standards have been shown to have a 
larger quantification range and greater sensitivity, reproducibility, and stability than RNA 
standards (Pfaffl, Tichopad et al. 2004). However, a DNA standard cannot be used for a one-
step real-time RT-PCR due to the absence of a control for the reverse transcription efficiency 
(Giulietti, Overbergh et al. 2001). 
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2. Relative quantitation 
During relative quantitation, changes in sample gene expression are measured based on 
either an external standard or a reference sample, also known as a calibrator (Livak and 
Schmittgen 2001). When using a calibrator, the results are expressed as a target/reference 
ratio. There are numerous mathematical models available to calculate the mean normalized 
gene expression from relative quantitationassays. Depending onthe method employed, 
these can yield different results and thus discrepant measures of standard error (Liu and 
Saint 2002; Muller, Janovjak et al. 2002). Table 1 shows a comparison of the different 
methods, with an explanation of each method to follow (Wong and Medrano 2005). 
9. Quantitative analyses 
For quantitative analysis, the amplification curves are evaluated. The amplification process 
is monitored either through the fluorescence of dsDNA-specific dyes (like SYBR Green I) or 
ofsequence-specific probes. Each curve consists of at least three distinct phases: 1) an initial 
lag phase in which no product accumulation can be measured, 2) an exponential phase, and 
3) a plateau phase (Wilhelm and Pingoud 2003). The exponential phase in principle could be 
extrapolated to the start of the reaction (Cycle 0) to calculate the template copy number, but 
the error would be too high. The template copy number can be estimated with greater 
precision from the number of cycles needed for the signal to reach an arbitrary threshold. 
The threshold must intersect the signal curve in its exponential phase, in which the signal 
increase correlates with product accumulation. The intersection point is the so-called 
threshold value (CT) or crossing point (CP). This point may be between two successive cycles 
(i.e. it may be a fractional number). For exact quantifications, the efficiency of the 
amplification reaction must be known. It is crucial that the amplification efficiencies of 
standards and unknowns are identical (Wilhelm and Pingoud 2003). The efficiency can be 
estimated from the CT values of samples with known template concentrations ('standards') 
as described below (Wilhelm and Pingoud 2003). 
During the exponential phase, the signal Scan be described by Equation 1: 
 S= pN0ɛc (1) 
wherepis a proportionality factor to relate PCR product concentration and signal intensity, 
N0is the amount of template, ɛis the amplification efficiency (1 ≤ ɛ ≤ 2; ɛ= 2 means 100% 
efficiency) and cis the cycle number. 
Solving for c results in Equation 2: 
 c=- (logɛ)-1(logN0 + logp- logS)  (2) 
With m= - (logɛ)-1 and b = - (logɛ)-1(logp-logS), Equation 2 simplifies to Equation 3: 
 c=mlogN0+ b (3) 
This equation describes the linear relationship between the CTvalues determined and the log 
of the template concentration (N0). The parameters mand bcan be determined by a regression 
analysis of the CT values of the standards. When solved for N0, this equation serves as a 
calibration curve for the calculation of the unknowns according to Equation 4: 
 N0 = 10(CT-b)/m (4) 
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Table 1. Characteristics of Relative Quantitation Methods 
 
Table 2. Characteristics of Detection Chemistries 
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Fig. 1. Real-time PCR detection chemistries. Probe sequences are shown in blue while target 
DNA sequences are shown in black. Primers are indicated by horizontal arrowheads. Not all 
unlabeled PCR primers are shown. Oligo, oligonucleotide. 
The efficiency can be calculated from the parameter m by using Equation 5: 
 ɛ = 10-1/m (5) 
By inserting ɛ back into Equation 4, one obtains Equation 6: 
 N0 = ɛ (b-CT) (6) 
The maximum value for ɛ is 2.0 (i.e. the amount of product is doubled in each cycle). The 
experimental value for ɛ usually varies between 1.5 and 1.9. Lower efficiencies limit the 
sensitivity of the assay but allow quantifications with higher precisions. Therefore, reactions 
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should be optimized for high efficiency. The effect of the efficiency on the precision, 
however, is not pronounced. 
With more than six orders of magnitude, the dynamic range of this procedure is 
extraordinarily high (Marcucci, Livak et al. 1998; Verhagen, Willemse et al. 2000;Sails, Fox et 
al. 2003). The accuracy of this technique is limited by the precision of the determination of 
the CT values. The error of the CT values results from the signal noise and the CT calculation 
method. In highly optimized assays, standard errors of less than ± 0.2 cycles can be 
achieved. By assuming an amplification efficiency of 2 (i.e. 100 %), this implies that the 
minimum relative error for the quantification is about 10- 20%. The effects of different 
analysis and calculation methods and the effects of amplification-independent signal trends 
on the accuracy and precision of quantifications by realtime PCR are described in detail in 
papers by Lui et al. and Wilhelm et al (Liu and Saint 2002; Wilhelm, Pingoud et al. 2003). 
Quantification is relative to the standard used. Only when the absolute concentration of the 
template molecules in the standard sample is known can the results be absolute. However, 
in most cases, determination of absolute concentrations is not required. That real-time PCR 
allows absolute quantification is demonstrated in principle by the reported determination of 
genome sizes (Wilhelm, Pingoud et al. 2003). 
All quantifications by PCR are relative, either to a standard or to a reference gene. 
Interestingly, Equation 6 nicely illustrates the relative character of the quantifications using 
a dilution series of a standard; the meaning of the parameter b is the expected CT value of a 
sample with 'one' copy (or any other unit as defined by the operator). The difference of this 
value minus the CT value determined for the unknown sample (∆CT = b - CT) is a direct 
measure for the relative difference in template concentrations of the unknown and standard 
(Wilhelm and Pingoud 2003). 
To analyse relative changes in transcript levels, the chosen standard is usually a reference 
transcript, for example from a housekeeping gene, itself with unknown template 
concentration. The calculation of ∆CT values between reference and sample transcript in a 
reference and a test sample then provides a simple tool to estimate relative changes. The 
derivation, assumptions and applications of the so-called 2∆∆CT method are described 
elsewhere by Livak et al (Livak and Schmittgen 2001). The results of this method are only 
semiquantitative because the efficiency ɛ is assumed to be 2.0 in all experiments and for all 
templates, which is at best an optimistic estimate. More precise results are obtained with a 
procedure introduced by Pfaffl et al., which includes a measured value for ɛ (Pfaffl 2001; 
Wilhelm and Pingoud 2003). 
In general, care must also be taken for accurate quantifications with external 
standardization, especially with respect to polymerase inhibitors, which may be present in 
differentconcentrations in the unknowns and standards. This problem is circumvented by 
internal standardization. Here, an analytically distinguishable standard template 
('competitor') is added to the sample and co-amplified in the same reaction (Gilliland, Perrin 
et al. 1990; Goerke, Bayer et al. 2001). The direct and simultaneous quantitative analysis of 
both products in realtime PCR also poses problems. These difficulties are mostly due to the 
fact that different fluorophors have to be used to distinguish the sequences of competitor 
and sample. As a result of different FRET and quantum efficiencies, the CT values obtained 
for competitor and sample are not directly comparable. 
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The problem of where to set the threshold makes relativequantifications difficult if not 
impossible. However, a simple trickcan be used to combine the advantages of both methods: 
thereaction mixtures are prepared in duplicate (Gibson, Heid et al. 1996). To one of 
thesemixtures, the probe specific for the competitor sequence isadded, whereas the probe 
specific for the sample sequence isadded to the other mixture. This process is carried out for 
a seriesof reactions with different amounts of competitor added. Withthis procedure, two 
calibration lines are obtained and theintersection of the two lines is the equivalence point 
(Wilhelm and Pingoud 2003). 
10. Melting curve analyses 
Melting curves represent the temperature dependence of the fluorescence. They are 
recorded subsequent to the amplification of the target sequence by PCR. The detection can 
be performed either with dsDNA-specific dyes like SYBR Green I or with sequence-specific 
probes such as the molecular beacons and the hybridisation probes (scorpion and sunrise 
primers cannot be used for melting curve analysis because they are integrated into the PCR 
products; TaqMan probes cannot be used for melting curve analyses either, since their signal 
generation depends on the hydrolysis of the probe). Melting curves of sequence-specific 
probes are used for genotyping, resolving single base mismatches between target sequence 
and probe (Lay and Wittwer 1997; Whitcombe, Brownie et al. 1998), whereas SYBR Green I 
is used most frequently for product characterization (Ririe, Rasmussen et al. 1997). It has 
been reported that melting curves measured with SYBR Green I can also be utilized for 
genotyping of insertion/deletion polymorphisms and of single nucleotide polymorphisms 
(SNPs) (Akey, Sosnoski et al. 2001; Lin, Tseng et al. 2001). 
In melting curves, the signal decreases gradually as a result of a temperature-dependent 
quench and more abruptly at a certain temperature because of the melting of the products 
(dsDNA or ssDNA/probe hybrid). The melting temperature (Tm) of a product is defined as 
the temperature at which the steepest decrease of signal occurs. This can be identified 
conveniently as the peak value(s) (global or local maxima) in the negative derivative of the 
melting curve. Additionally, the area under the curve (AUC) of the peaks is proportional to 
the amount of product. Therefore, melting curve analysis may be used for quantifications 
with internal standardization when the Tm values of sample and competitor products are 
significantly different (Al-Robaiy, Rupf et al. 2001). However, well-performed normalization 
is required to reduce the systematic error due to the temperature dependent quench. This 
quench also limits the sensitivity of melting curve analyses. At present, there is only one 
software package available that can remove the quench effects from the data (Wilhelm, 
Pingoud et al. 2003). 
With SYBR Green I, the amplification of the correct target sequence can be confirmed. In 
most cases, nonspecific products have different lengths and therefore deviating melting 
temperatures (Ririe, Rasmussen et al. 1997).Hybridisation probes, molecular beacons and 
TaqMan probes are used for mutation detection (Lay and Wittwer 1997; Bernard, Ajioka et 
al. 1998; Bernard and Wittwer 2000), genotyping (Whitcombe, Brownie et al. 1998; Ulvik and 
Ueland 2001; Grant, Steinlicht et al. 2002; Randen, Sørensen et al. 2003) and SNP screening 
(Sasvari‐Szekely, Gerstner et al. 2000; Mhlanga and Malmberg 2001). 
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11. Applications 
Real-time PCR is used for absolute and relative quantifications of DNA and RNA template 
molecules and for genotyping in a variety of applications (Wilhelm and Pingoud 2003). 
Quantitative real-time PCR is used to determine viral loads (Mackay, Arden et al. 
2002),gene expression (Bustin 2000; Goerke, Bayer et al. 2001), titers of germs and 
contaminations (infood, blood, other body fluids and tissues) (Locatelli, Urso et al. 2000; 
Hernandez, Rio et al. 2001; Norton 2002), allele imbalances (Ruiz-Ponte, Loidi et al. 2000) 
and the degrees of amplification and deletion ofgenes (Chiang, Wei et al. 1999; Nigro, 
Takahashi et al. 2001). 
Real-time PCR is also becoming increasingly important in thediagnosis of tumors, such as 
for the detection and monitoringof minimal residual diseases (Marcucci, Livak et al. 1998; 
Elmaagacli, Beelen et al. 2000; Amabile, Giannini et al. 2001; Krauter, Heil et al. 2001; 
Krauter, Hoellge et al. 2001), the identification of micrometastases in colorectal cancer 
(Bustin, Gyselman et al. 1999), neuroblastoma (Cheung and Cheung 2001) and prostate 
cancer (Gelmini, Tricarico et al. 2001). It has been used to quantify amplifications of 
oncogenes (Bieche, Laurendeau et al. 1999; Lehmann, Glöckner et al. 2000; Lyon, Millson et 
al. 2001; Konigshoff, Wilhelm et al. 2003) as well as deletions of tumor suppressor genes in 
tumor samples (Wilhelm and Pingoud 2003). Also, the response of human cancer to drugs 
has been studied (Au, Chim et al. 2002; Miyoshi, Ando et al. 2002;Reimer, Koczan et al. 
2002). Other clinically relevant applications are cytokine mRNA profiling in immune 
response (Hempel, Smith et al. 2002; Stordeur, Poulin et al. 2002) and tissue-specific gene 
expression analysis (Bustin 2002; Poola 2003; Prieto-Alamo, Cabrera-Luque et al. 2003).  
Also, the results of DNA chip experiments are validated by real-time PCR quantifications 
(Miyazato, Ueno et al. 2001; Rickman, Bobek et al. 2001;Crnogorac-Jurcevic, Efthimiou et al. 
2002). 
Chimerism analysis is possible when sequence-specific probes are utilized to differentiate 
and quantify alleles. High dynamic ranges can be achieved with allele-specific real-time 
PCR (Shively, Chang et al. 2003). Robust chimerism analyses with extremely large dynamic 
ranges based on insertion/deletion polymorphisms and on SNPs are also possible (Wilhelm, 
Reuter et al. 2002; Maas, Schaap et al. 2003). Genetic chimerisms have been monitored by Y-
chromosome-specific real-time PCR for sex-mismatched transplantations (Fehse, 
Chukhlovin et al. 2001; Byrne, Huang et al. 2002; Elmaagacli 2002) and by allele-specific real-
time PCR (Maas, Schaap et al. 2003; Shively, Chang et al. 2003). This combination of allele-
specific amplification with real-time PCR has been shown to reveal detection limits of 
down to 0.01% for SNPs (Maas, Schaap et al. 2003). Real-time PCR is increasingly used in 
forensic analyses (Andreasson, Gyllensten et al. 2002; von Wurmb-Schwark, Higuchi et al. 
2002; Ye, Parra et al. 2002), but also to monitor disease- or age-related accumulation of 
deletions in the mitochondrial genome (Mehmet, Ahmed et al. 2001; He, Chinnery et al. 
2002). 
Melting curve analyses are used for real-time competitive PCR (Al-Robaiy, Rupf et al. 2001; 
Lyon, Millson et al. 2001), gene dosage tests (Ruiz-Ponte, Loidi et al. 2000) and genotyping 
and SNP detection (Bullock, Bruns et al. 2002; Burian, Grosch et al. 2002; Randen, Sørensen 
et al. 2003). These applications will have a particularly strong impact on pharmacogenetics 
(Palladino, Kay et al. 2003). Profiling of DNA methylation is also possible by melting curve 
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analysis (Worm, Aggerholm et al. 2001; Akey, Akey et al. 2002), which simplifies the 
analysis of epigenetic variations of the genome and developmental processes. 
In brief, the advantages of real-time PCR are exploited in clinical diagnosis and the 
monitoring of infectious diseases and tumors. The technique is applied for the analysis of 
age dependent diseases, cytokine and tissue-specific expression, forensic samples, epigenetic 
factors like DNA methylation and for food monitoring. The field of applications is still 
growing rapidly, which suggests that real-time PCR will become one of the most important 
techniques in molecular life sciences and medicine (Wilhelm and Pingoud 2003). 
12. Normalization 
Gene expression analysis at the messenger RNA (mRNA) level has become increasingly 
important in biological research. Generally we detect RNAs to determine if differences 
protein expression could be explained at the transcriptional level. In particular, 
measurement of mRNA is needed in situations where quantification of the protein is 
difficult or cumbersome. Most recently, mRNA expression analysis is being used to provide 
insight into complex regulatory networks and to identify genes relevant to new biological 
processes or implicated in diseases (Hendriks-Balk, Michel et al. 2007).Common methods for 
RNA detection include: Northern blotting, in situ hybridization, qualitative RTPCR, RNase 
protection assay, competitive RT-PCR, microarray analysis, and quantitative real-time PCR. 
The specificity, wide dynamic range , ease-of-use , requiring a minimal amount of RNA, no 
post-PCR handling and avoiding the use of radioactivity, has made the real-time 
quantitative reverse transcription polymerase chain reaction (qRT-PCR) the method of 
choice for quantitating RNA levels (Radonic, Thulke et al. 2004). The technique has two 
main steps: CDNA synthesis by reverse transcription of mRNA and subsequent 
quantification of specific CDNAs by real-time PCR. It is in many cases the only method for 
measuring mRNA levels of vivo low copy number targets of interest for which alternative 
assays either do not exist or lack the required sensitivity so these specification has led to 
made it the "gold standard" for mRNA quantification (Huggett, Dheda et al. 2005). Most 
gene expression assays are based on the comparison of two or more samples and require 
uniform sampling conditions for this comparison to be valid. Unfortunately, many factors 
can contribute to variability in the analysis of samples, making the results difficult to 
reproduce between experiments. During the preparation of CDNA for real-time PCR 
analysis there is significant potential for small errors to accumulate. For example, 
differences in sample size, RNA extraction efficiency, pippetting accuracy and reverse 
transcription efficiency will all add variability to your samples (Huggett, Dheda et al. 
2005). Not only can the quantity and quality of RNA extracted from multiple samples 
vary, but even replicates can vary dramatically due to factors such as sample degradation, 
extraction efficiency, and contamination. On the other hand, since many biological 
samples contain inhibitors of the RT and/or the PCR step, it is crucial to assess the 
presence of any inhibitors of polymerase activity in RT and PCR. so it is clear that we 
need to incorporate some normalization method to control for errors. The identification of 
a valid reference for data normalisation remains the most stubborn of problems and none 
of the solutions proposed are ideal. Normalization methods range from ensuring that a 
similar sample size is chosen to using an internal housekeeping or reference gene (Table 
3) (Huggett, Dheda et al. 2005). 
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(Huggett, Dheda et al. 2005) 
Table 3. Comparison of the actual amount of RNA used in different reverse transcription 
reactions with the respective amount of HuPO 
Comparison of the actual amount of RNA used in different reverse transcription reactions 
with the respective amount of HuPO  
cDNA measured by real-time RT-PCR 
12.1 Methods of normalization 
1. Standardizing Sample size 
The most basic method of normalization ensures that an experiment compares similar 
sample sizes and this is achieved by measuring tissue weight, volume or cell number. This 
method can reduce the experimental error of first stage of qRT-PCR. It seems to be 
straightforward, but we can’t ensure that equal volume of different samples contain the 
same cellular material. Real-time RT-PCR experiments that rely on the extraction of RNA 
from complex tissue samples are averaging the data from numerous, variable 
subpopulations of cells of different lineage at different stages of differentiation (Bustin, 
Benes et al. 2005). This can be misleading, as is illustrated when sampling a similar volume 
of blood from HIV +ve patients. Patients with HIV that have less advanced 
immunosupression (CD4 counts X200 cells/ml) will yield a higher amount RNA than 
patients with CD4 counts p200 cells/ml. This is simply because there are fewer cells per 
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milliliter of blood in the latter group. Even cellular subpopulations of the same pathological 
origin can be highly heterogeneous. Tumor biopsies, in particular, are made up not just of 
normal and cancer epithelial cells, but there may be several subclones of epithelial cancer 
cells together with stromal, immune and vascular components (Vandesompele, De Preter et 
al. 2002; Bustin, Benes et al. 2005). This variability can give us misleading or meaningless 
result to solve this we can use laser capture microdissection to normalize against the 
dissected area which can report the target mRNA levels conveniently as copies per area or 
cell dissected. In in vitro cell culture, due to different morphologies or clumping up of cells, 
it’s hard to determine sample size (cell number) .we can treat them with buffers and/or 
enzymes till they could be counted, however these treatments surely could affect gene 
expression. This approach could not be applied for solid tumors for which the amount of 
cells cannot be determined accurately. To work around this problem, it was suggested to 
standardize the RT-qPCR data between samples using the amount of genomic DNA as an 
indicator reflecting the number of cells in each sample. However, these approaches do not 
account for the degradation of RNA or the efficiency of RT and PCR. So, while ensuring a 
similar sample size is important it clearly is not sufficient on its own (Huggett, Dheda et al. 
2005).  
2. Normalization with genomic DNA  
Another method for normalization is measuring the amount of genomic DNA (gDNA). This 
appears to be an ideal method as it does not require reverse transcription for detection by 
real-time PCR (Bustin 2002). However, this approach do not account for the degradation of 
RNA or the efficiency of RT and PCR. .Moreover, in the case of normalization with genomic 
DNA, the fact of working with tumor cells can present additional problems because they 
tend to have abnormal karyotype. Therefore, the ratio between the amount of DNA and cell 
number is variable (Huggett, Dheda et al. 2005). Another major problem with using this 
strategy is that RNA extraction procedures are usually not designed to purify DNA, so the 
extraction rate may vary between different samples, with DNA yields often being low. In 
conclude Normalization against genomic DNA is rarely used since it is difficult to coextract 
with RNA and it may vary in copy number per cell (Huggett, Dheda et al. 2005). 
3. Normalization with total RNA 
The normalization of RT-qPCR results can be compared to the amount of total RNA used in 
the reverse transcription step. Not only does this facilitates normalization but circumvents 
problems associated with the linearity of the reverse transcriptase step. There are several 
methods for quantifying RNA; the most common is to measure the absorbance at 260 nm 
(A 260) with a UV spectrophotometer. The major advantage of this spectrometer, whose 
sensitivity is estimated at 5 ng/uL, is that it requires only 1 microL of sample, placed in 
direct contact with the optical system (Huggett, Dheda et al. 2005; Hendriks-Balk, Michel et 
al. 2007). However, contaminants absorbing at 260 nm, such as proteins, phenol or genomic 
DNA, can lead to overestimated results. Another optical system is flourimetry in which 
intercalating fluorescent nucleic acid is used, the kit RiboGreen ® Molecular Probes based on 
this principle. This is a more sensitive technique but does not discriminate RNA from DNA, 
and contaminants such as phenol can produce variable results (Huggett, Dheda et al. 2005). 
Since it is generally assumed that OD260 analysis is less accurate than the RiboGreen assay, 
we have compared RNA quantification data obtained using the RiboGreen assay with 
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OD260 analysis using a Genequant II (Pharmacia). The results (Fig. 2) suggest that both 
methods generate comparable results when the RNA concentration is not less than 100 
ng/μl, with RiboGreen measurements lower than those obtained using the 
spectrophotometer. OD260 analysis becomes less reliable at lower RNA concentrations 
(Bustin 2002). 
 
Fig. 2. Comparison of RNA quantification using the Genequant II and the RiboGreen 
fluorescent assay. RNA from 34 normal colon biopsies was quantitated using a standard 
Genequant II protocol which measures the absorbance at 260 nm. The same samples were 
then quantitated using a standard RiboGreen fluorescent assay. RT-PCR assays targeting the 
GHR were carried out and Ct normalised against the respective concentrations determined 
by the two methods. The scatterplot shows a good correlation between the two methods 
(r2=0·8612) (Bustin 2002). 
What is also important, but often overlooked, is the need to assess the quality of RNA 
because degraded RNAs may adversely affect results. The opportune development of 
Agilent’s 2100 Bioanalyser and LabChip technology has provided a new standard of RNA 
quality control as well as permitting concomitant quantification of RNA. The analysis is not 
influenced by contamination of phenol or proteins, against the presence of genomic DNA 
requires a correction of the measurement of the concentration of RNA (Bustin, Benes et al. 
2005). This is particularly important when the RNA has been extracted from ‘dirty’ tissue 
such as the colon (Vandesompele, De Preter et al. 2002). This technique allows 
characterizing the RNA in a concentration between 5 and 500 ng/uL. For each sample, the 
software determines the ratio 28S/18S and assigns a RIN (RNA Integrity Number) which 
takes into account the entire electropherogram. The value of RIN ranges from 1 to 10, with 1 
being totally degraded RNA, and 10 to a high-quality RNA. In addition to being fast and 
allow high throughput, this technique requires only 1 microL of sample. It is the simplest 
method and objective qualitative analysis of RNA, its use is recommended (Schmittgen and 
Zakrajsek 2000; Bustin 2002). Similar in concept, but requiring an additional RT-PCR assay, 
is normalization against one of the rRNAs. rRNA levels may vary less under conditions that 
affect the expression of mRNAs and the use of rRNA has been claimed to be more reliable 
than that of several reference genes in rat livers and human skin fibroblasts (Bustin 2002; 
Huggett, Dheda et al. 2005). But, a drawback is that it primarily measures ribosomal RNA 
(rRNA) whereas real-time PCR aims to determine mRNA expression and normalization for 
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total RNA assumes that the rRNA:mRNA ratio is the same in all groups, which might not 
always be the case. Moreover, rRNA is not present in purified mRNA and the high 
abundance of rRNA compared to mRNA makes it difficult to subtract the baseline value in 
realtime PCR analysis. Thus, markers of rRNA such as 18S or 28S rRNA might also be 
suboptimal as normalization factors in many settings (Hendriks-Balk, Michel et al. 2007). 
Also, it has been reported that rRNA transcription is affected by biological factors and 
drugs. An important parameter to consider when normalized relative to the RNA is the 
quality of it. Differences in the quality of the samples strongly depend on the extraction step 
and are the source of the most common variations in RT-qPCR. It is therefore important to 
use the same method of extraction for all samples analyzed (Vandesompele, De Preter et al. 
2002). The quality of RNA is defined by both its purity (no contamination) and integrity 
(non-degraded RNA). Its purity was determined by measuring the absorbance at 230 
(organic contaminants) and 280 nm (specific proteins), RNA is considered pure ratios A 260/ 
A 230 and A 260 / A 280 > 1.8. With regard to the integrity, the traditional method was to 
visualize the bands of 28S and 18S ribosomal RNA on a gel electrophoresis. Indeed, it is 
difficult to analyze directly the mRNA; they represent only 1% to 3% of total RNA. We must 
therefore consider that the degradation of ribosomal RNA, the majority, reflecting the 
degradation of mRNA. Thus, the 18S/28S ratio assesses the integrity of RNA; a ratio close to 
2 is considered an indicator of RNA with little or no gradient. However, this method 
requires a large amount of RNA (0.5-2 mg), and is not sensitive enough to detect slight 
damage. Normalizing a sample against total RNA has the drawback of not controlling for 
variation inherent in the reverse transcription or PCR reactions and it ignores the efficiency 
of converting RNA into CDNA. Also rRNA cannot be used for normalization when 
quantifying targets from polyA-enriched samples (Huggett, Dheda et al. 2005). A final 
drawback when using total RNA for normalization is the lack of internal control for RT or 
PCR inhibitors. All quantitative methods assume that the RNA targets are reverse 
transcribed and subsequently amplified with similar efficiency but the reaction is extremely 
sensitive to the presence of inhibitors, which can be reagents used in the extraction step 
(salts, alcohols, phenols), or components copurification organic (urea, heme, heparin, 
immunoglobulin G). These compounds can also inhibit the PCR reaction. Thus, two 
reactions with an equal amount of RNA, but the efficiencies of RT and / or PCR are 
different, will yield results that cannot be compared. Different methods exist to assess the 
presence of inhibitors in biological samples. First, it is possible to compare the efficacy of 
PCR for different dilutions (1/20 and 1/80 for example) of a sample. An alternative is to add 
a defined amount of a synthetic single-stranded amplicon CDNA samples, and comparing 
its amplification compared to a control without CDNA. However, these methods are limited 
to verify the absence of PCR inhibitors, and do not evaluate the effectiveness of the reverse 
transcription step (Bustin 2002). 
4. Normalization with an artificial molecule (spike) 
An interesting solution to control the two enzymatic reactions (RT and PCR) is added to 
RNA extracted an exogenous RNA, which will compare the amplification between the 
different samples. This sequence control should show no similarity to the target RNA, we 
will use such a specific mRNA from a plant when studying gene expression in humans. The 
main criticism of using spikes is that, while they can be introduced prior to extraction, 
unlike the cellular RNAs they are not extracted from within the tissue. Consequently, there 
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may be situations (e.g. if the samples differ histologically) when the spike may not be a good 
control for the extraction procedure. The stages required to generate the alien molecule may 
also not be feasible for small laboratories wanting to perform limited amounts of real-time 
RTPCR (Schmittgen and Zakrajsek 2000; Argyropoulos, Psallida et al. 2006).  
5. Normalization with reference genes  
Reference genes represent the by far most common method for normalizing qRT-PCR data. 
Reference genes are often referred to as housekeeping genes assuming that those genes are 
expressed at a constant level in various tissues at all stages of development and are 
unaffected by the experimental treatment (Hendriks-Balk, Michel et al. 2007; Balogh, Paragh 
et al. 2008). Use of this endogenous control theory allows controlling all stages of the 
experimental protocol; its expression reflects not only the quantity and quality of RNA used, 
but the efficiencies of the RT and PCR. An advantage of reference genes as compared to total 
or rRNA is that the reference gene is subject to the same conditions as the mRNA of interest 
(Hendriks-Balk, Michel et al. 2007). The most commonly used reference genes include β-
actin (ACTB), (GAPDH), (HPRT) and 18S rRNA. The other commonly used reference genes 
would be PGK1, B2M, GAPD, HMBS, HPRT1, RPL13A, SDHA, TBP, UBC and YWHAZ 
(Vandesompele, De Preter et al. 2002). The initial concentration of a target is usually derived 
from the CT (cycle threshold), which is the number of amplification cycles where the 
amplification curve crosses the threshold line. This line is placed at the exponential phase, so 
as to be clearly distinguishable from background noise. For each sample, the CT obtained for 
the genes of interest and reference must be converted to normalized expression ratio. For 
this, various options are available, they are integrated in the software provided with the 
various qPCR instruments or described in the literature. The relative standard curve method 
requires the construction, for the target gene and reference gene, a range made from a series 
of dilutions of a reference sample. These ranges to obtain standard curves, obtained by 
expressing the CT as a function of log of the initial concentration of cDNA. Concentration 
values for each point of the range can be set arbitrarily in accordance with the dilution 
factors. Therefore, the relative amount of a target is determined by the CT by interpolation 
with the standard curve. The standard expression of a gene of interest is determined by the 
following formula: 
R= 
ೃ೐೗ೌ೟೔ೡ೐ ೌ೘೚ೠ೙೟ ೚೑ ೟೓೐ ೒೐೙೐ ೚೑ ೔೙೟ೝ೐ೞ೟ோ௘௟௔௧௜௩௘ ௔௠௢௨௡௧ ௢௙ ௧௛௘ ௥௘௙௥௘௡௖௘ ௚௘௡௘ 
In addition, a calibrator is typically used. This is a sample used as a basis for comparing 
results. The normalized ratio of each sample is divided by the normalized ratio of the 
calibrator. Thus, the calibrator becomes the reference 1x, and all other samples are expressed 
as a ratio relative to the calibrator. The method of ΔΔC T uses a mathematical formule to 
calculate the ratio of expression of a target gene between two samples, normalized with 
reference gene. First, the differences ΔC T between the values of CT target gene and reference 
gene were determined for the test sample and control.  
ΔCT (sample) = CT (target sample) - CT (reference sample) 
ΔCt (control) = CT (target control) - CT (reference control) 
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Next, the ΔΔCT between control and the sample is calculated:  
ΔΔCT ΔCT (control) - ΔCT (sample)  
Finally, the normalized ratio of expression of a target gene is determined by the formula: 2 -
ΔΔCT.  
Unlike the relative standard curve method, where the amplification efficiency (E) target 
genes and reference is directly taken into account when building ranges, the method of 
ΔΔCT is assumed that the efficiencies of the two genes are equal to 100% (E = 2, with each 
cycle of the exponential phase, the concentration of PCR products is doubled). However, a 
difference in PCR efficiency of 3% (ΔE = 0.03) between the two genes results in an error of 
47% for the ratio of expression if E target <E ref and 209% if E target > E ref after 25 cycles. In 
addition, the error increases exponentially with larger variations of efficiency and a greater 
number of cycles. New models have been developed taking into account the efficiency of 
PCR target gene and reference gene. The most common is the model of Pfaffl, where the 
relative expression ratio (R) of a target gene between a sample and control is determined by 
the following formula: 
R = 
ሺா౪౗౨ౝ౛౪ ሻΔి ౐౪౗౨ౝ౛౪ሺౙ౥౤౪౨౥ౢ ష౩౗ౣ౦ౢ౛ ሻሺா౨౛౜౛౨౛౤ౙ౛ ሻΔి ౐౨౛౜౛౨౛౤ౙ౛ሺౙ౥౤౪౨౥ౢ ష౩౗ౣ౦ౢ౛ ሻ  
In this model of Pfaffl, the efficiency of PCR for a given gene is calculated from the 
construction of a calibration curve using the following formula: E = 10 [-1/ gradient]. This 
method gives a good estimate of effectiveness, although it is possible that it is 
overestimated. However, this approach assumes that the amplification efficiencies between 
the diluted samples are identical, creating a linear relationship between C T and amount of 
CDNA in the beginning. Therefore, some authors such as Liu and Saint have developed 
models that take into account standards of efficiency for each sample, the latter being 
determined by the kinetics of the amplification curve. However, with this kind of approach, 
the slightest error in the measurement of effectiveness is amplified and passed exponentially 
on the expression ratio calculated. The different models of normalization with reference 
genes therefore have all the advantages and disadvantages. At present, there is no time-
honored method for the treatment of the results of RT-qPCR. Normalization to a reference 
gene is a simple method and frequently used because it can control many variables. An 
advantage of reference genes as compared to total or rRNA is that the reference gene is 
subject to the same conditions as the mRNA of interest (Bustin, Benes et al. 2005; Hendriks-
Balk, Michel et al. 2007). What has become apparent over recent years is that there is no 
single reference gene for all experimental systems. Quantified errors related to the use of a 
single reference gene as more than three-fold in 25% and more than six-fold in 10% of 
samples. Today it is clear that reference genes must be carefully validated for each 
experimental situation and those new experimental conditions or different tissue samples 
require re-validation of the chosen reference genes (Balogh, Paragh et al. 2008). If 
inappropriate reference genes are used for normalization, the experimental results obtained 
can differ greatly from those using a validated reference gene. Validation of a reference gene 
requires removal of any non-specific variation in expression. This can be done using a 
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recently introduced program called geNorm (freely available at 
http://medgen.ugent.be/~jvdesomp/genorm/) that mathematically identifies the most 
suitable reference gene for a given experimental condition. Because of the inherent variation 
in the expression of reference genes the use of multiple reference genes rather than one 
reference gene is recommended to ensure reliable normalization of real-time PCR. Several 
statistical programs can help to determine the most appropriate reference gene or set of 
genes (Hendriks-Balk, Michel et al. 2007; Borges, Ferreira et al. 2010). 
13. Abbreviation 
ACTB: Beta actin  
B2M: Beta-2-microglobulin  
CT: Threshold Cycle 
FRET: Fluorescence Resonance Energy Transfer 
GAPD: Glyceraldehyde-3- phosphate dehydrogenase  
HMBS: Hydroxymethyl-bilane synthase  
HPRT: hypoxanthine ribosyltransferase  
HPRT1: Hypoxanthine phosphoribosyl-transferase 1  
HRM: High Resolution Melting 
KPCR: Kinetic Polymerase Chain Reaction 
LNA: Locked Nucleic Acid 
LUX: Light Upon Extension 
PCR: Polymerase Chain Reaction 
PGK1: phosphoglycerokinase 1  
PNA: Peptide Nucleic Acid 
Q-PCR (QRT-PCR): Quantitative Real-Time Polymerase Chain Reaction  
RPL13A: Ribosomal protein L13a  
RT PCR: Reverse transcription PCR 
SDHA: Succinate dehydrogenase complex, subunit A  
TBP: TATA box binding protein  
Tm: Melting Point 
UBC: Ubiquitin C  
YWHAZ: Tyrosine 3-monooxygenase/ tryptophan 5-monooxygenase activation protein, 
zeta polypeptide  
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